These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 24759208

  • 1. Physiologic doses of depot-medroxyprogesterone acetate do not increase acute plasma simian HIV viremia or mucosal virus shedding in pigtail macaques.
    Radzio J, Hanley K, Mitchell J, Ellis S, Deyounks F, Jenkins LT, Hanson D, Heneine W, García-Lerma JG.
    AIDS; 2014 Jun 19; 28(10):1431-9. PubMed ID: 24759208
    [Abstract] [Full Text] [Related]

  • 2. A Depot Medroxyprogesterone Acetate Dose That Models Human Use and Its Effect on Vaginal SHIV Acquisition Risk.
    Butler K, Ritter JM, Ellis S, Morris MR, Hanson DL, McNicholl JM, Kersh EN.
    J Acquir Immune Defic Syndr; 2016 Aug 01; 72(4):363-71. PubMed ID: 27355414
    [Abstract] [Full Text] [Related]

  • 3. Analysis of putative mucosal SHIV susceptibility factors during repeated DMPA treatments in pigtail macaques.
    Butler K, Ritter J, Ellis S, Henning TR, Montague J, Zaki S, Garber D, McNicholl JM, Kersh EN.
    J Med Primatol; 2015 Oct 01; 44(5):286-95. PubMed ID: 26238265
    [Abstract] [Full Text] [Related]

  • 4. Repeated administration of high-dose depot medroxyprogesterone acetate does not alter SHIVSF162p3 viral kinetics and tenofovir pharmacokinetics when delivered via intravaginal rings.
    Srinivasan P, Zhang J, Dinh CT, Teller RS, McNicholl JM, Kiser PF, Herold BC, Smith JM.
    J Med Primatol; 2017 Aug 01; 46(4):129-136. PubMed ID: 28748662
    [Abstract] [Full Text] [Related]

  • 5. Human vaginal histology in long-term users of the injectable contraceptive depot-medroxyprogesterone acetate.
    Bahamondes MV, Castro S, Marchi NM, Marcovici M, Andrade LA, Fernandes A, Bahamondes L.
    Contraception; 2014 Aug 01; 90(2):117-22. PubMed ID: 24613369
    [Abstract] [Full Text] [Related]

  • 6. Progestin-based contraception regimens modulate expression of putative HIV risk factors in the vaginal epithelium of pig-tailed Macaques.
    Bosinger SE, Tharp GK, Patel NB, Zhao C, Payne TL, Dietz Ostergaard S, Butler K, Ellis S, Johnson RL, Kersh EN, McNicholl JM, Vishwanathan SA.
    Am J Reprod Immunol; 2018 Oct 01; 80(4):e13029. PubMed ID: 30076667
    [Abstract] [Full Text] [Related]

  • 7. Effect of the depot medroxyprogesterone acetate injectable and levonorgestrel implant on HIV genital shedding: a randomized trial.
    Chinula L, Nelson JAE, Wiener J, Tang JH, Hurst S, Tegha G, Msika A, Ellington S, Hosseinipour MC, Mataya R, Haddad LB, Kourtis AP.
    Contraception; 2018 Sep 01; 98(3):193-198. PubMed ID: 29746813
    [Abstract] [Full Text] [Related]

  • 8. Depot-medroxyprogesterone acetate does not reduce the prophylactic efficacy of emtricitabine and tenofovir disoproxil fumarate in macaques.
    Radzio J, Hanley K, Mitchell J, Ellis S, Deyounks F, Jenkins L, Heneine W, García-Lerma JG.
    J Acquir Immune Defic Syndr; 2014 Dec 01; 67(4):365-9. PubMed ID: 25202923
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. RT-SHIV, an infectious CCR5-tropic chimeric virus suitable for evaluating HIV reverse transcriptase inhibitors in macaque models.
    Jiang Y, Tian B, Saifuddin M, Agy MB, Emau P, Cairns JS, Tsai CC.
    AIDS Res Ther; 2009 Nov 05; 6():23. PubMed ID: 19891783
    [Abstract] [Full Text] [Related]

  • 11. Genital Injury Signatures and Microbiome Alterations Associated With Depot Medroxyprogesterone Acetate Usage and Intravaginal Drying Practices.
    Birse KD, Romas LM, Guthrie BL, Nilsson P, Bosire R, Kiarie J, Farquhar C, Broliden K, Burgener AD.
    J Infect Dis; 2017 Feb 15; 215(4):590-598. PubMed ID: 28011908
    [Abstract] [Full Text] [Related]

  • 12. The effect of depot medroxyprogesterone acetate on tenofovir alafenamide in rhesus macaques.
    Daly MB, Sterling M, Holder A, Dinh C, Nishiura K, Khalil G, García-Lerma JG, Dobard C.
    Antiviral Res; 2021 Feb 15; 186():105001. PubMed ID: 33385420
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Sexually transmitted infections and depot medroxyprogesterone acetate do not impact protection from simian HIV acquisition by long-acting cabotegravir in macaques.
    Vishwanathan SA, Zhao C, Luthra R, Khalil GK, Morris MM, Dinh C, Gary MJ, Mitchell J, Spreen WR, Pereira LE, Heneine W, García-Lerma JG, McNicholl JM.
    AIDS; 2022 Feb 01; 36(2):169-176. PubMed ID: 34482355
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Depot medroxyprogesterone acetate increases immune cell numbers and activation markers in human vaginal mucosal tissues.
    Chandra N, Thurman AR, Anderson S, Cunningham TD, Yousefieh N, Mauck C, Doncel GF.
    AIDS Res Hum Retroviruses; 2013 Mar 01; 29(3):592-601. PubMed ID: 23189932
    [Abstract] [Full Text] [Related]

  • 18. Use of contraceptive depot medroxyprogesterone acetate is associated with impaired cervicovaginal mucosal integrity.
    Zalenskaya IA, Chandra N, Yousefieh N, Fang X, Adedipe OE, Jackson SS, Anderson SM, Mauck CK, Schwartz JL, Thurman AR, Doncel GF.
    J Clin Invest; 2018 Oct 01; 128(10):4622-4638. PubMed ID: 30222141
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Medroxyprogesterone acetate levels among Kenyan women using depot medroxyprogesterone acetate in the FEM-PrEP trial.
    Nanda K, Callahan R, Taylor D, Wang M, Agot K, Jenkins D, Van Damme L, Dorflinger L, FEM-PrEP Study Group.
    Contraception; 2016 Jul 01; 94(1):40-7. PubMed ID: 26972780
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.